| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3573407
[patent_doc_number] => 05539086
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-23
[patent_title] => 'Therapeutic fragments of von Willebrand factor'
[patent_app_type] => 1
[patent_app_number] => 8/198849
[patent_app_country] => US
[patent_app_date] => 1994-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12083
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/539/05539086.pdf
[firstpage_image] =>[orig_patent_app_number] => 198849
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/198849 | Therapeutic fragments of von Willebrand factor | Feb 17, 1994 | Issued |
Array
(
[id] => 3817349
[patent_doc_number] => 05789558
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Protein prenyltransferase'
[patent_app_type] => 1
[patent_app_number] => 8/188277
[patent_app_country] => US
[patent_app_date] => 1994-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 6
[patent_no_of_words] => 8761
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/789/05789558.pdf
[firstpage_image] =>[orig_patent_app_number] => 188277
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/188277 | Protein prenyltransferase | Jan 30, 1994 | Issued |
Array
(
[id] => 3514764
[patent_doc_number] => 05576205
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-19
[patent_title] => 'Kainate-binding human CNS receptors of the EAA1 family'
[patent_app_type] => 1
[patent_app_number] => 8/185232
[patent_app_country] => US
[patent_app_date] => 1994-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10098
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/576/05576205.pdf
[firstpage_image] =>[orig_patent_app_number] => 185232
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/185232 | Kainate-binding human CNS receptors of the EAA1 family | Jan 23, 1994 | Issued |
Array
(
[id] => 3623635
[patent_doc_number] => 05607914
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-04
[patent_title] => 'Synthetic antimicrobial peptides'
[patent_app_type] => 1
[patent_app_number] => 8/179632
[patent_app_country] => US
[patent_app_date] => 1994-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5544
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/607/05607914.pdf
[firstpage_image] =>[orig_patent_app_number] => 179632
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/179632 | Synthetic antimicrobial peptides | Jan 6, 1994 | Issued |
Array
(
[id] => 3550219
[patent_doc_number] => 05547928
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-20
[patent_title] => 'Methods and compositions for the detection of colon cancers'
[patent_app_type] => 1
[patent_app_number] => 8/168993
[patent_app_country] => US
[patent_app_date] => 1993-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7936
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/547/05547928.pdf
[firstpage_image] =>[orig_patent_app_number] => 168993
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/168993 | Methods and compositions for the detection of colon cancers | Dec 16, 1993 | Issued |
Array
(
[id] => 3588158
[patent_doc_number] => 05585259
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'Ecotin as a factor Xa, XIa, and XIIa inhibitor'
[patent_app_type] => 1
[patent_app_number] => 8/165304
[patent_app_country] => US
[patent_app_date] => 1993-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5172
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585259.pdf
[firstpage_image] =>[orig_patent_app_number] => 165304
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/165304 | Ecotin as a factor Xa, XIa, and XIIa inhibitor | Dec 9, 1993 | Issued |
| 08/164170 | HEPARIN-BINDING BRAIN MITOGENS | Dec 7, 1993 | Abandoned |
| 08/164103 | V1-1 COMPOSITIONS | Dec 6, 1993 | Abandoned |
Array
(
[id] => 3695026
[patent_doc_number] => 05595886
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-21
[patent_title] => 'Protein complexes having Factor VIII:C activity and production thereof'
[patent_app_type] => 1
[patent_app_number] => 8/161770
[patent_app_country] => US
[patent_app_date] => 1993-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14232
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/595/05595886.pdf
[firstpage_image] =>[orig_patent_app_number] => 161770
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/161770 | Protein complexes having Factor VIII:C activity and production thereof | Dec 2, 1993 | Issued |
| 08/159697 | VECTORS FOR THE EXPRESSION OF HIRUDIN, TRANSFORMED CELLS AND PROCESS FOR THE PREPARATION OF HIRUDIN | Nov 30, 1993 | Abandoned |
Array
(
[id] => 3514555
[patent_doc_number] => 05576190
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-19
[patent_title] => 'Bacteriophage Lambda pL promoters'
[patent_app_type] => 1
[patent_app_number] => 8/156325
[patent_app_country] => US
[patent_app_date] => 1993-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7222
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/576/05576190.pdf
[firstpage_image] =>[orig_patent_app_number] => 156325
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/156325 | Bacteriophage Lambda pL promoters | Nov 22, 1993 | Issued |
Array
(
[id] => 3652893
[patent_doc_number] => 05658567
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Recombinant .alpha.-galactosidase A therapy for Fabry disease'
[patent_app_type] => 1
[patent_app_number] => 8/155734
[patent_app_country] => US
[patent_app_date] => 1993-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6898
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658567.pdf
[firstpage_image] =>[orig_patent_app_number] => 155734
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/155734 | Recombinant .alpha.-galactosidase A therapy for Fabry disease | Nov 21, 1993 | Issued |
Array
(
[id] => 3847942
[patent_doc_number] => 05766909
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'DNA encoding inducible nitric oxide synthase'
[patent_app_type] => 1
[patent_app_number] => 8/147812
[patent_app_country] => US
[patent_app_date] => 1993-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 10623
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/766/05766909.pdf
[firstpage_image] =>[orig_patent_app_number] => 147812
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/147812 | DNA encoding inducible nitric oxide synthase | Nov 4, 1993 | Issued |
Array
(
[id] => 3409713
[patent_doc_number] => 05460955
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-10-24
[patent_title] => 'Fibronectin purification vector'
[patent_app_type] => 1
[patent_app_number] => 8/145061
[patent_app_country] => US
[patent_app_date] => 1993-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5431
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/460/05460955.pdf
[firstpage_image] =>[orig_patent_app_number] => 145061
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/145061 | Fibronectin purification vector | Oct 27, 1993 | Issued |
| 08/139891 | INTERFERON TAU COMPOSITIONS AND METHODS OF USE | Oct 18, 1993 | Abandoned |
Array
(
[id] => 3443622
[patent_doc_number] => 05420025
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-05-30
[patent_title] => 'Recombinant transglutaminase'
[patent_app_type] => 1
[patent_app_number] => 8/136993
[patent_app_country] => US
[patent_app_date] => 1993-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14972
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/420/05420025.pdf
[firstpage_image] =>[orig_patent_app_number] => 136993
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/136993 | Recombinant transglutaminase | Oct 17, 1993 | Issued |
| 08/133438 | VIBRIO CHOLERAE NON-01 SEROGROUP VACCINE STRAINS, METHODS OF MAKING SAME AND PRODUCTS THEREOF | Oct 7, 1993 | Abandoned |
| 08/133439 | VIBRIO CHOLERAE CVD111, METHOD OF MAKING SAME, AND VACCINE DERIVED THEREFROM | Oct 7, 1993 | Abandoned |
Array
(
[id] => 3514616
[patent_doc_number] => 05576194
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-19
[patent_title] => 'Recombinant protein production'
[patent_app_type] => 1
[patent_app_number] => 8/130404
[patent_app_country] => US
[patent_app_date] => 1993-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5439
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/576/05576194.pdf
[firstpage_image] =>[orig_patent_app_number] => 130404
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/130404 | Recombinant protein production | Sep 30, 1993 | Issued |
| 08/125559 | THE FACTOR VIII BINDING DOMAIN OF VON WILLEBRAND FACTOR | Sep 22, 1993 | Abandoned |